Skip to content

Study on the brain network mechanism of deep cervical lympho-venous anastomosis based on fNIRS in the treatment of Alzheimer's disease

Deep cervical-venous anastomosis (LVA) for the treatment of Alzheimer's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105493
Enrollment
Unknown
Registered
2025-07-04
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

Undergoing LVA surgery group:Bilateral deep cervical lymph-venous anastomosis
Not undergoing LVA surgery group:None

Sponsors

General Hospital of the Central Theater of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: (1) Age 55~80 years old; (2) The subject has received primary school education or above and is able to complete the prescribed cognitive ability tests and other tests; (3) memory impairment for at least 12 months, with a gradual deterioration trend; (4) Diagnosed with AD according to the 2024 National Institute on Aging-Alzheimer's Society diagnostic criteria for AD; (5) Mild to severe disease, with a score of <= 20 on the Concise Mental State Examination (MMSE); (6) Hamilton Depression Rating Scale total score <= 10 points; (7) head MRI and oblique coronal hippocampal scan, which showed the highest probability of AD; (8) Subjects had stable and reliable caregivers, or at least frequent contact with caregivers (at least 4 days a week, at least 2 hours a day).

Exclusion criteria

Exclusion criteria: Exclusion Criteria: (1) Dementia caused by other causes, including vascular dementia, central nervous system infection, Creutzfeldt-Jakob disease, Huntington's disease, Parkinson's disease, Lewy body dementia, traumatic dementia, other physical and chemical factors (such as drug poisoning, alcoholism, carbon monoxide poisoning, etc.), major physical diseases (such as hepatic encephalopathy), intracranial mass lesions (such as brain tumors), endocrine disorders or other factors; (2) History of neurological diseases (including stroke, neuromyelitis optica, Parkinson's disease, epilepsy); (3) Unstable or severe cardiac, pulmonary, hepatic, renal or hematopoietic diseases; (4) visual or auditory impairment that interferes with the completion of neuropsychological tests and scale assessments; (5) alcohol or drug abuse; (6) suffer from mental illness, including major depression; (7) The subject was unable to cooperate with the operation and postoperative management.

Design outcomes

Primary

MeasureTime frame
Blood oxygen signal;Mini-Mental State Examination score;Alzheimer’s disease assessment scale-cognitive subscale score;Alzheimer’s disease cooperative study scale for activities of daily living score;

Secondary

MeasureTime frame
neuropsychiatric inventory score;

Countries

China

Contacts

Public ContactSong Jian

General Hospital of the Central Theater of the Chinese People's Liberation Army

xrang@163.com+86 182 7182 5295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026